The local gene-sequencing company and a U.S. clothing company face sales restrictions in China as part of that country’s ...

Gene sequencing machine maker Illumina forecast 2025 revenue largely below Wall Street estimates on Thursday, signaling ...

Shares of Illumina (NASDAQ:ILMN) slid 5% in post-market trading after it released its Q4 earnings report and reiterated its 2025 guidance, despite the company facing potential sanctions in China amid ...

Leading American genomic sequencing firm Illumina says it is evaluating Beijing’s announcement with hope of ‘positive ...

McKinsey and Co., the US multinational strategy and management consultancy, is reportedly questioning its presence in China ...

China announced retaliatory tariffs on select American imports and an antitrust investigation into Google on Tuesday, just ...

Illumina, the San Diego-based gene sequencing giant, is taking a hit this week after China placed the company on its ...

Tariffs of 10 percent on all Chinese imports took effect on Feb. 4, 2025, following President Donald Trump's executive order under the ...

Trump aggressively targeted China during his first term and increased tariffs another 10 per cent this week, prompting ...

Chinese regulators have been in discussions with Apple executives and app developers since last year over fee concerns.

China announced it would impose additional tariffs on certain US imports from February 10, 2025 in retaliation to ...